Education
About Us
Working with TipRanks
Follow Us
Heron Therapeutics (HRTX)
NASDAQ:HRTX
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 154.90M | $ 144.28M | $ 127.04M | $ 107.67M | $ 86.35M |
| Gross Profit | $ 113.56M | $ 105.64M | $ 61.94M | $ 52.80M | $ 40.33M |
| Operating Income | $ -2.54M | $ -11.53M | $ -110.61M | $ -174.66M | $ -217.83M |
| EBITDA | $ -17.88M | $ -5.06M | $ -103.79M | $ -176.66M | $ -215.25M |
| Net Income | $ -20.20M | $ -13.58M | $ -110.56M | $ -182.02M | $ -220.68M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 46.63M | $ 59.28M | $ 80.41M | $ 84.85M | $ 157.58M |
| Total Assets | $ 255.88M | $ 233.15M | $ 222.51M | $ 250.95M | $ 305.71M |
| Total Debt | $ 140.64M | $ 177.76M | $ 179.63M | $ 157.48M | $ 159.50M |
| Net Debt | $ 111.99M | $ 151.96M | $ 150.95M | $ 142.11M | $ 68.95M |
| Total Liabilities | $ 241.54M | $ 266.80M | $ 256.48M | $ 237.38M | $ 228.14M |
| Stockholders' Equity | $ 14.33M | $ -33.65M | $ -33.97M | $ 13.57M | $ 77.57M |
| Cash Flow | |||||
| Free Cash Flow | $ -27.91M | $ -24.23M | $ -60.33M | $ -148.74M | $ -206.38M |
| Operating Cash Flow | $ -27.59M | $ -22.53M | $ -58.79M | $ -146.91M | $ -203.35M |
| Investing Cash Flow | $ 16.01M | $ 18.71M | $ 18.00M | $ -3.32M | $ 32.73M |
| Financing Cash Flow | $ 14.43M | $ 940.00K | $ 54.11M | $ 75.06M | $ 156.03M |